Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Onconetix advanced an additional $500,000 to Realbotix LLC under its strategic bridge financing facility, bringing total principal outstanding to $3 million. The non-interest bearing Grid Note allows up to $5 million in aggregate loans and is automatically cancelled and discharged upon closing of the pending all-stock Share Exchange Agreement; if the deal terminates, interest accrues at 12% per annum.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.